Sodium-glucose cotransporter 2 inhibitors and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Background: Patients with type 2 diabetes mellitus (T2DM) have an increased risk of fracture compared with those without T2DM. Some oral glucose-lowering agents may increase the incidence of fracture. Whether sodium-glucose co-transporter 2 inhibitors (SGLT2is) are associated with increased risk of fracture remains unclear.

Metal-organic framework-derived CeO-ZnO catalysts for CH-SCR of NO: an DRIFTS study.

Metal-organic framework (MOF)-based derivatives have attracted an increasing interest in various research fields. Here, we synthesized CeO-ZnO catalysts through the complete thermal decomposition of the Ce/MOF-5 precursor. The catalysts were characterized using XRD, FTIR, TG-DSC, SEM and H-TPR.